• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去甲基化酶LSD1自杀性失活剂的机制分析

Mechanistic analysis of a suicide inactivator of histone demethylase LSD1.

作者信息

Szewczuk Lawrence M, Culhane Jeffrey C, Yang Maojun, Majumdar Ananya, Yu Hongtao, Cole Philip A

机构信息

Department of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

出版信息

Biochemistry. 2007 Jun 12;46(23):6892-902. doi: 10.1021/bi700414b. Epub 2007 May 19.

DOI:10.1021/bi700414b
PMID:17511474
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2531293/
Abstract

Lysine-specific demethylase 1 (LSD1) is a transcriptional repressor and a flavin-dependent amine oxidase that is responsible for the removal of methyl from lysine 4 of histone H3. In this study, we characterize the mechanism and scope of LSD1 inhibition by a propargylamine-derivatized histone H3 substrate (1). Unlike aziridinyl and cyclopropylamine-derivatized histone H3 peptide substrate analogues, compound 1 appears to covalently modify and irreversibly inactivate LSD1 with high potency. Accompanying this inactivation is a spectroscopic change, which shifts the absorbance maximum to 392 nm. Spectral changes associated with the 1-LSD1 complex and reactivity to decreased pH and sodium borohydride treatment were suggestive of a structure involving a flavin-linked inhibitor conjugate between N5 of the flavin and the terminal carbon of the inhibitor. Using a 13C-labeled inhibitor, NMR analysis of the 1-flavin conjugate was consistent with this structural assignment. Kinetic analysis of the spectroscopic shift induced by 1 showed that the flavin adduct formed in a reaction with kinetic constants similar to those of the LSD1 inactivation process. Taken together, these data support a mechanism of LSD1 inactivation by 1 involving amine oxidation followed by Michael addition to the propargylic imine. We further examined the potential for a biotinylated analogue of 1 (1-Btn) to be used as a tool in affinity pulldown experiments. Using 1-Btn, it was feasible to selectively pull down spiked and endogenous LSD1 from HeLa cell nuclear extracts, setting the stage for activity-based demethylase proteomics.

摘要

赖氨酸特异性去甲基化酶1(LSD1)是一种转录抑制因子,也是一种黄素依赖性胺氧化酶,负责去除组蛋白H3赖氨酸4位上的甲基。在本研究中,我们表征了一种炔丙胺衍生化的组蛋白H3底物(1)对LSD1的抑制机制和范围。与氮丙啶基和环丙胺衍生化的组蛋白H3肽底物类似物不同,化合物1似乎能高效地共价修饰并不可逆地使LSD1失活。伴随这种失活的是光谱变化,其最大吸光度移至392nm。与1-LSD1复合物相关的光谱变化以及对降低pH值和硼氢化钠处理的反应性表明,其结构涉及黄素N5与抑制剂末端碳之间的黄素连接抑制剂共轭物。使用13C标记的抑制剂,对1-黄素共轭物的核磁共振分析与该结构归属一致。对1诱导的光谱位移进行动力学分析表明,在反应中形成的黄素加合物的动力学常数与LSD1失活过程的相似。综上所述,这些数据支持1使LSD1失活的机制,即胺氧化后迈克尔加成到炔丙基亚胺上。我们进一步研究了1的生物素化类似物(1-Btn)用作亲和下拉实验工具的潜力。使用1-Btn,从HeLa细胞核提取物中选择性下拉掺入的和内源性LSD1是可行的,这为基于活性的去甲基酶蛋白质组学奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/b319970c88c8/nihms62394f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/f87d6506aa04/nihms62394f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/be5797035cf1/nihms62394f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/91ba72ecfc43/nihms62394f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/48b8376f46f6/nihms62394f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/50962fd8ed8c/nihms62394f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/ef39aaa0b529/nihms62394f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/7e6c498da9c3/nihms62394f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/b319970c88c8/nihms62394f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/f87d6506aa04/nihms62394f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/be5797035cf1/nihms62394f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/91ba72ecfc43/nihms62394f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/48b8376f46f6/nihms62394f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/50962fd8ed8c/nihms62394f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/ef39aaa0b529/nihms62394f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/7e6c498da9c3/nihms62394f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59e0/2531293/b319970c88c8/nihms62394f8.jpg

相似文献

1
Mechanistic analysis of a suicide inactivator of histone demethylase LSD1.组蛋白去甲基化酶LSD1自杀性失活剂的机制分析
Biochemistry. 2007 Jun 12;46(23):6892-902. doi: 10.1021/bi700414b. Epub 2007 May 19.
2
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.反式-2-苯基环丙胺是一种基于机制的组蛋白去甲基化酶LSD1失活剂。
Biochemistry. 2007 Apr 10;46(14):4408-16. doi: 10.1021/bi0618621. Epub 2007 Mar 17.
3
Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors.小分子和组蛋白底物类似物作为 LSD1 赖氨酸去甲基酶抑制剂的比较分析。
J Am Chem Soc. 2010 Mar 10;132(9):3164-76. doi: 10.1021/ja909996p.
4
A mechanism-based inactivator for histone demethylase LSD1.一种基于机制的组蛋白去甲基化酶LSD1失活剂。
J Am Chem Soc. 2006 Apr 12;128(14):4536-7. doi: 10.1021/ja0602748.
5
Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine.抗抑郁药反式-2-苯基环丙胺抑制LSD1组蛋白去甲基化酶的结构基础
Biochemistry. 2007 Jul 10;46(27):8058-65. doi: 10.1021/bi700664y. Epub 2007 Jun 15.
6
Human histone demethylase LSD1 reads the histone code.人类组蛋白去甲基化酶LSD1解读组蛋白密码。
J Biol Chem. 2005 Dec 16;280(50):41360-5. doi: 10.1074/jbc.M509549200. Epub 2005 Oct 13.
7
Structural basis of histone demethylation by LSD1 revealed by suicide inactivation.自杀失活揭示的LSD1介导组蛋白去甲基化的结构基础
Nat Struct Mol Biol. 2007 Jun;14(6):535-9. doi: 10.1038/nsmb1255. Epub 2007 May 27.
8
A novel mammalian flavin-dependent histone demethylase.一种新型的哺乳动物黄素依赖性组蛋白去甲基化酶。
J Biol Chem. 2009 Jun 26;284(26):17775-82. doi: 10.1074/jbc.M109.003087. Epub 2009 Apr 30.
9
LSD1 Histone Demethylase Assays and Inhibition.赖氨酸特异性去甲基化酶1(LSD1)的组蛋白去甲基化酶检测与抑制
Methods Enzymol. 2016;573:261-78. doi: 10.1016/bs.mie.2016.01.020. Epub 2016 Feb 23.
10
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.由核胺氧化酶同源物LSD1介导的组蛋白去甲基化作用
Cell. 2004 Dec 29;119(7):941-53. doi: 10.1016/j.cell.2004.12.012.

引用本文的文献

1
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1.通过工程化赖氨酸脱甲基酶LSD1来解开组蛋白修饰的串扰。
Nat Chem Biol. 2025 Feb;21(2):227-237. doi: 10.1038/s41589-024-01671-9. Epub 2024 Jul 4.
2
Are Terminal Alkynes Necessary for MAO-A/MAO-B Inhibition? A New Scaffold Is Revealed.末端炔基对于 MAO-A/MAO-B 的抑制是否必需?一种新的支架结构被揭示。
Molecules. 2024 May 24;29(11):2486. doi: 10.3390/molecules29112486.
3
Inhibition of LSD1 promotes the differentiation of human induced pluripotent stem cells into insulin-producing cells.抑制 LSD1 可促进人诱导多能干细胞向胰岛素分泌细胞分化。
Stem Cell Res Ther. 2020 May 19;11(1):185. doi: 10.1186/s13287-020-01694-8.
4
Jumonji C Demethylases in Cellular Senescence.Jumonji C 去甲基化酶在细胞衰老中的作用。
Genes (Basel). 2019 Jan 9;10(1):33. doi: 10.3390/genes10010033.
5
Evidence for a Cyanine Link Between Propargylamine Drugs and Monoamine Oxidase Clarifies the Inactivation Mechanism.炔丙胺类药物与单胺氧化酶之间存在花青连接的证据阐明了失活机制。
Front Chem. 2018 May 28;6:169. doi: 10.3389/fchem.2018.00169. eCollection 2018.
6
Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.新型组蛋白 H3 肽基 LSD1 失活剂的设计、合成及体外评价,其中包含具有 γ-转角诱导结构的α,α-二取代氨基酸。
Molecules. 2018 May 6;23(5):1099. doi: 10.3390/molecules23051099.
7
Kinetics, mechanism, and inhibition of monoamine oxidase.单胺氧化酶的动力学、机制和抑制作用。
J Neural Transm (Vienna). 2018 Nov;125(11):1659-1683. doi: 10.1007/s00702-018-1861-9. Epub 2018 Mar 7.
8
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.通过丙氨酸扫描诱变鉴定出的具有更高活性的赖氨酸特异性去甲基化酶1的环肽抑制剂。
Eur J Med Chem. 2018 Mar 25;148:210-220. doi: 10.1016/j.ejmech.2018.01.098. Epub 2018 Feb 7.
9
New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.新型组蛋白去甲基化酶 LSD1 抑制剂选择性靶向畸胎瘤和胚胎癌细胞。
Bioorg Med Chem. 2018 May 1;26(8):1523-1537. doi: 10.1016/j.bmc.2018.01.031. Epub 2018 Feb 7.
10
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.用双组蛋白去乙酰化酶和去甲基化酶抑制剂靶向CoREST复合物。
Nat Commun. 2018 Jan 4;9(1):53. doi: 10.1038/s41467-017-02242-4.

本文引用的文献

1
trans-2-Phenylcyclopropylamine is a mechanism-based inactivator of the histone demethylase LSD1.反式-2-苯基环丙胺是一种基于机制的组蛋白去甲基化酶LSD1失活剂。
Biochemistry. 2007 Apr 10;46(14):4408-16. doi: 10.1021/bi0618621. Epub 2007 Mar 17.
2
Dynamic regulation of histone lysine methylation by demethylases.去甲基化酶对组蛋白赖氨酸甲基化的动态调控。
Mol Cell. 2007 Jan 12;25(1):1-14. doi: 10.1016/j.molcel.2006.12.010.
3
Activity-based protein profiling reagents for protein arginine deiminase 4 (PAD4): synthesis and in vitro evaluation of a fluorescently labeled probe.用于蛋白质精氨酸脱亚氨酶4(PAD4)的基于活性的蛋白质谱试剂:一种荧光标记探针的合成与体外评估
J Am Chem Soc. 2006 Nov 15;128(45):14468-9. doi: 10.1021/ja0656907.
4
A highly specific mechanism of histone H3-K4 recognition by histone demethylase LSD1.组蛋白去甲基化酶LSD1识别组蛋白H3-K4的一种高度特异性机制。
J Biol Chem. 2006 Nov 17;281(46):35289-95. doi: 10.1074/jbc.M607411200. Epub 2006 Sep 20.
5
Crystal structure of human histone lysine-specific demethylase 1 (LSD1).人类组蛋白赖氨酸特异性去甲基化酶1(LSD1)的晶体结构
Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):13956-61. doi: 10.1073/pnas.0606381103. Epub 2006 Sep 6.
6
Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.人类LSD1组蛋白去甲基化酶对核小体进行CoREST依赖性去甲基化的结构基础。
Mol Cell. 2006 Aug 4;23(3):377-87. doi: 10.1016/j.molcel.2006.07.012.
7
Crystal structure and mechanism of human lysine-specific demethylase-1.人类赖氨酸特异性去甲基化酶-1的晶体结构与作用机制
Nat Struct Mol Biol. 2006 Jul;13(7):626-32. doi: 10.1038/nsmb1113. Epub 2006 Jun 25.
8
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications.组蛋白H3赖氨酸4去甲基化是非选择性抗抑郁药物的作用靶点。
Chem Biol. 2006 Jun;13(6):563-7. doi: 10.1016/j.chembiol.2006.05.004.
9
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases.组蛋白去甲基化酶JMJD2家族对组蛋白赖氨酸三甲基化的逆转作用。
Cell. 2006 May 5;125(3):467-81. doi: 10.1016/j.cell.2006.03.028. Epub 2006 Apr 6.
10
A mechanism-based inactivator for histone demethylase LSD1.一种基于机制的组蛋白去甲基化酶LSD1失活剂。
J Am Chem Soc. 2006 Apr 12;128(14):4536-7. doi: 10.1021/ja0602748.